A phase II trial comparing pazopanib with doxorubicin as first-line treatment in elderly patients with metastatic or advanced soft tissue sarcoma (EPAZ): study protocol for a randomized controlled trial

BACKGROUND: Anthracycline-based treatment remains the backbone of chemotherapy for nonresectable soft tissue sarcomas (STS). More than 30 % of patients with STS are aged 60 years or older, limiting the choice of treatment to single-agent approaches for this elderly population. Hematological toxicity...

Descripción completa

Detalles Bibliográficos
Autores principales: Karch, Annika, Koch, Armin, Grünwald, Viktor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936293/
https://www.ncbi.nlm.nih.gov/pubmed/27387325
http://dx.doi.org/10.1186/s13063-016-1434-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936293/
https://www.ncbi.nlm.nih.gov/pubmed/27387325
http://dx.doi.org/10.1186/s13063-016-1434-x

Ejemplares similares